Quick Search Form

Book Title: Treating and Preventing Adolescent Mental Health Disorders  > pp. [345]-[349]
Click here to open a preview window containing the current page in a printer-friendly form Printer Friendly   go to page    previous  |  next

 
Figure 17.4 Trends in 2-week prevalence of binge drinking in three populations.
Figure 17.4 Trends in 2-week prevalence of binge drinking in three populations.
dence and related problems are the National Household Surveys mentioned above (e.g., SAMHSA, 2002a) and the National Comorbidity Study (Anthony, Warner, & Kessler, 1994; Kessler, 1994). However, as is explained above, it is still too soon to derive much from the NCS with specific regard to adolescents.
Subgroup Differences in Substance Use
Not all adolescent and young adult subgroups in society are at equal risk of being a recently active drug user (Johnston et al., 2002a; Wallace et al., 2003). During adolescence, at least, African-American youngsters have substantially lower prevalence of use of the full range of legal and illegal substances than their white, Hispanic, or Native American counterparts, although there seems to be some reversal of this difference in early and later adulthood (SAMHSA, 2002a). Native Americans tend to have the highest prevalence of use, and in early adolescence, Hispanic youth tend to have the next highest. Adolescent boys are somewhat more likely than girls to use most drugs, and quite a bit more likely to use them frequently. Van Etten, Anthony, and colleagues have pursued a line of research that traces the basic male–female difference in drug experience back to an earlier male excess in the experience of the first chance to try drugs; that
Table 17.1 How Many Have Ever Received Drug Treatment or Counseling?: Cumulative Proportion (%) Estimated for Each Year, 1988–2001
Grade
1988–1989
1990–1991
1992–1993
1994–1995
1996–1997
1998–1999
2000–2001
Average
8
  
2.9
2.7
3.3
3.0
2.8
2.9
10
  
2.7
3.1
3.9
3.9
4.0
3.5
12 (total)
3.7
3.6
3.3
3.9
4.5
4.7
4.1
4.0
12 (residential)
1.2
1.1
1.1
1.5
1.4
1.2
1.1
1.2
12 (outpatient)
3.3
3.4
2.9
3.4
3.9
4.5
3.7
3.6
Source: Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2002a). National survey results from the Monitoring the Future study, 1975–2001. Volume I: Secondary school students. Bethesda, MD: National Institute on Drug Abuse.
end p.345
Table 17.2 How Many Received Drug Treatment or Counseling Each Year?: Prevalence Proportion (%) Estimated for Each Year, 1988–2001
Grade
1988–1989
1990–1991
1992–1993
1994–1995
1996–1997
1998–1999
2000–2001
Average
8
  
1.4
1.2
1.5
1.4
1.4
1.4
10
  
1.3
1.5
1.9
2.0
1.9
1.7
12 (total)
1.6
1.6
1.6
1.9
2.3
2.2
1.9
1.9
12 (residential)
0.4
0.2
0.4
0.5
0.4
0.5
0.5
0.4
12 (outpatient)
1.6
1.5
1.4
1.8
2.1
2.1
1.7
1.7
Source: Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2002a). National survey results from the Monitoring the Future study, 1975–2001. Volume I: Secondary school students. Bethesda, MD: National Institute on Drug Abuse.
is, males have the chance to try illegal drugs earlier than girls and at any given age are more likely to have experienced a chance to try these drugs. However, once the first chance to try a drug is presented, girls are just as likely as boys to actually consume the drug (e.g., see Van Etten & Anthony, 2001; Van Etten, Neumarks, & Anthony, 1999). Contrary to popular opinion, rural areas now generally do not have lower prevalence of most types of drug use than more urban areas, and sometimes actually have higher rates, which speaks to how thoroughly the drug epidemic has diffused to all parts of American society. The finding that most forms of drug use do not vary much as a function of the educational level of the parents, a measure of socioeconomic status, also reflects this diffusion. The use of certain drugs does tend to concentrate in particular regions of the country—crystal methamphetamine use in the West, for example—but for the most part regional similarities are more noteworthy than the differences. Sometimes, when a new drug is coming onto the scene, such as crack in the 1980s and ecstasy in the late 1990s, there are larger geographic differences until the diffusion process takes place. Most of the demographic and family background subgroup differences mentioned above tend to enlarge during periods of greater use of a drug and to diminish during periods of contraction in use; but still they tend to remain consistent as to direction over long historical periods, with very few exceptions. Regional differences in cocaine use expanded dramatically in the early 1980s, at the height of the cocaine epidemic, with the West and the Northeast United States attaining considerably higher prevalence of use than the South or the North Central. But during the contraction period that followed, beginning in 1997, the West and Northeast also showed the most dramatic declines (Johnston, et al., 2003b).
An International Comparison
The American drug epidemic of the 1960s and 1970s spread around the globe, as a mobile generation of young people traveled the world. Even so, illegal drug use generally did not penetrate so deeply into youth populations of other countries. A recent 30-country prevalence survey of illegal drug use among 15-year-olds (mostly in European countries) shows generally larger values for American adolescents than for any of the 30 other countries (Hibell et al., 2000). Despite the long-ago passing of forces giving special impetus to the American epidemic, and despite progress in prevention, we still are in the top rank.
A caution is in order, however. When an epidemic has occurred, as happened with cocaine in the 1970s and early 1980s, it can give rise to a considerable population of continuing, dependent users. A result is that “casualty” counts of impaired users needing treatment can lag behind general trends in prevalence of use.
end p.346
CLINICAL ASPECTS OF SPECIFIC SUBSTANCE USE DISORDERS
Our understanding of adolescent addiction, in both pharmacological and behavioral realms, is somewhat limited, and research advances in this area have been thwarted by several considerations. First, the typical pharmacologic experiments involving controlled administration of drugs commonly done with adult research volunteers for the most part have not been possible with adolescents. Thus much of what is known about the pharmacology of drugs in adolescents must be inferred from experience with adults. The logistics, particularly ethical, regulatory, and related informed-consent issues, are such that much of the pharmacologic research on drugs that adolescents should not be using must necessarily take place with animal models or with adult volunteers. Of course, useful information can be learned from clinical experience and observations, but even our clinical experience has been limited by adolescent resistance to treatment, by social stigma, and by an inadequate addiction treatment infrastructure in the United States. Furthermore, anecdotal clinical information is much less reliable than that gleaned from controlled studies, as have been performed on adult substance abusers. Experience from clinical settings, such as emergency rooms and treatment clinics, provides information on the pharmacology of adverse drug consequences, but provides less information on the more typical pharmacologic effects of illicit drug use experienced by the majority of adolescent users who never appear for treatment of adverse consequences.
Another consideration when describing effects of drugs in adolescents is that it is traditional to present and discuss the pharmacology of each drug or drug class individually. However, adolescents who abuse drugs, particularly those of most concern who use drugs regularly, seldom take only one drug during an evening or day of drug use. All of the drugs reviewed here are typically used more in various combinations rather than individually. For example, when considering the pharmacology of cannabis, hardly anyone begins to use cannabis regularly before becoming experienced with alcohol and tobacco, although recent data suggest this pattern may be changing. More often than not, after becoming a regular user, all of these three drugs (and often others) are used in close proximity or together. This is true to varying degrees for all the drugs attractive to some adolescents. The pharmacology and toxicity of drug combinations can be complex and different from the pharmacology of the drugs used individually.
Heroin and Other Opioid Dependence in Adolescence
Most adolescents view heroin to be extremely dangerous and few if any plan to become addicted to this agent. Yet heroin use has increased since 1992 among all age groups and the average age of first time use has declined (SAMHSA, 1997). Furthermore, heroin is now available to adolescents living in urban, suburban, and even rural settings, where alarming numbers of adolescents are seeking treatment for heroin addiction and presenting to emergency rooms with heroin-related problems. There has also been an uptrend among adolescents in the abuse of prescription pills with opioid agonist action (see Table 17.3) that are capable of producing the same clinical elements characteristic of heroin dependence. In past years heroin was primarily injected and the reluctance of adolescents to use needles probably provided a significant barrier to their first-time use. But the purity of heroin has increased significantly and the drug is now widely administered by the less efficient but more socially acceptable nasal route, making first-time use less onerous to adolescents who are
Table 17.3 Opioid Pain Relievers
Codeine (Phenergan, Robitussin)
Hydrocodone (Hycodan)
Hydromorphone (Dilaudid)
Meperidine (Demerol)
Methadone (Dolophine)
Morphine (Roxanol)
Oxycodone (Oxycontin, Percocet, Percodan)
Pentazocine (Talwin)
Propoxyphene (Darvocet, Darvon)
end p.347
introduced to heroin by peers, acquaintances, and family members. In addition, a precipitous decline in the price of heroin has made the drug affordable to adolescents.
Data on adolescents from the National Household Surveys on Drug Use and Health (NHSDUH) reported that in the 12-to 17-years age range, there were 47,000 active heroin users in the United States (0.2% prevalence), of which 34,000 had recently begun using heroin (0.1% incidence) (SAMHSA, 2000). Chen and Anthony (under review) studied the clinical course of adolescent heroin users by analyzing NHSDUH data from calendar years 2000 and 2001 and found that approximately 22% of first-time users became addicted. In addition, clinical features reported by the adolescent heroin users (time spent seeking heroin and recovering from its effects, failed efforts to quit, dose escalation, continued use despite emotional and physical problems, reduction in nondrug activities) were generally much greater than corresponding estimates for stimulants, alcohol, marijuana, hallucinogens, sedative and hypnotics, and inhalants. There are approximately 1,262,000 adolescents using prescription pain relievers (5.4% prevalence), 722,000 recent-onset users (3.3% incidence), and a 9% likelihood of becoming addicted (SAMHSA, 2000).
The addictiveness of heroin stems largely from the intense euphoria associated with heroin intoxication. Heroin euphoria has been compared to sexual orgasm or described as “God's warmest blanket” by heroin users who often become obsessed with the drug. The rewarding effect of heroin and of all opioid agonists derives from their ability to activate endogenous opioid receptors that densely populate reward-related brain regions. Opioid receptors are normally activated by endogenous opioid peptides (i.e., β-endorphin, enkephalin, dynorphin) that play important roles in natural reward and satiety (Dackis & O'Brien, 2003b). An injection of heroin leads to a rush of euphoria that lasts several minutes and is followed by a persistent period of sedation and satiety, during which time the user typically nods and falls asleep. It is noteworthy that this tranquil response to heroin contrasts markedly with the stimulation, gregariousness, and intense craving that follows cocaine use.
Tolerance develops more rapidly to the rewarding effect of heroin than to its toxic effects, such as respiratory depression, which increases the risk of lethal overdose in users pursuing euphoria. In the presence of adequate supply, heroin users can progressively increase their daily dose by 100-fold. Street heroin varies widely in potency and unusually pure shipments are notorious for leaving a trail in the medical examiner's office. Although naloxone (an opioid receptor antagonist) rapidly reverses heroin overdose, timely medical treatment is often unavailable in adolescent overdose situations that can easily result in death. Heroin is often used in combination with other drugs of abuse: benzodiazepines, cocaine, alcohol, marijuana, and prescription opioids. It is common for intravenous users to inject heroin and cocaine simultaneously (termed “speedballing”) to experience additive subjective effects of these agents.
Heroin addiction produces marked functional impairment in adolescents as they progressively lose control over the amount used and over behaviors directed toward heroin procurement. Reports indicate that the risk of developing specific clinical features of drug dependence is consistently greater for heroin than other drugs of abuse (SAMHSA, 2002a). School performance, family relations, and social functioning typically deteriorate significantly as heroin becomes the adolescent's first priority. Heroin-addicted adolescents often resort to illegal activities, including shoplifting, dealing, prostitution, and robbery, as a means of paying for their increasing heroin dose requirement. Consequently, they risk arrest, conviction, and incarceration, along with the stigma and disadvantages that are associated with a criminal record. Heroin users also risk physical trauma associated with the dangerous drug-seeking lifestyle. As their heroin addiction intensifies, adolescents are usually shielded from their impairment by denial, an essential feature of the addiction. Minimization, rationalization, intellectualization, and other aspects of denial must be addressed by treatment interventions that make adolescents aware of their loss of control.
Adolescents who experiment with heroin are often surprised by the rapid onset of heroin withdrawal. Heroin withdrawal symptoms usu
end p.348
ally emerge within days or weeks after the first use of heroin, typically emerging within 8 to 12 hr of abstinence and lasting for 3 to 5 days. Physiological, genetic, and psychological factors can significantly affect the duration and severity of heroin withdrawal. It is noteworthy that the signs and symptoms of heroin withdrawal are diametrically opposite those of heroin intoxication. This phenomenon results from the fact that compensatory brain responses to chronically administered heroin are unopposed during heroin abstinence, resulting in rebound withdrawal symptoms (O'Brien, 2001). Although the heroin withdrawal syndrome (see Table 17.4) is extremely unpleasant, it is not medically dangerous.
Heroin-addicted individuals experience panic and intense irritability during withdrawal, and their urgent drive for heroin often leads to risky drug-seeking behaviors. This tendency is compounded in adolescents who are characteristically impulsive. Generally, heroin users will actively avoid withdrawal symptoms by using heroin on a regular and daily basis. Consequently, the binge pattern of use that is charac teristic of cocaine dependence is seldom reported among heroin users. Heroin users routinely experience withdrawal symptoms when their supply of heroin or money is interrupted. Furthermore, severely addicted individuals must use heroin several times per day to avoid withdrawal, and are constantly oscillating between periods of heroin intoxication and withdrawal, creating a vicious cycle that positively (euphoria) and negatively (withdrawal/craving) reinforces continued heroin use. When alcohol or other sedatives (benzodiazepines, barbiturates) are also abused, sedative withdrawal symptoms may complicate the symptoms of opioid withdrawal.
Cocaine and Other Stimulant Dependence in Adolescence
Cocaine is the most heavily abused nervous system stimulant in the United States and therefore the primary focus of this section. Other central stimulants (most notably methamphetamine, amphetamine, and dextroamphetamine) pro
Table 17.4 Signs and Symptoms of Heroin Intoxication and Withdrawal
Heroin Intoxication
Heroin Withdrawal
Signs (Observed)
Bradycardia
Tachycardia
Low blood pressure
Elevated blood pressure
Low body temperature
Fever, sweats
Sedation
Insomnia
Small (pinpoint) pupils
Enlarged pupils
Reduced movement
Pacing
Slurred speech
Piloerection (“gooseflesh”)
Head nodding
Yawning, tearing, runny nose
Slow breathing
Increased breathing rate
Symptoms (Reported)
Euphoria
Anxiety, depression
Reduced pain threshold
Bone and muscle pain
Calmness
Cramps, nausea, vomiting, diarrhea
Satiation
Craving for heroin
 
Restlessness, irritability
 
Reduced pain threshold
end p.349
  go to page    previous  |  next

 
doi:10.1093/9780195173642.003.0018
-->
Contents
 
scroll up fast
scroll up
 
scroll down
scroll down fast

Return to Top